AVON, Conn.--(BUSINESS WIRE)--Magellan Health, Inc. (NASDAQ: MGLN) today announced that Dr. Karen Amstutz has been named as the company’s chief medical officer, responsible for setting the strategic roadmap and vision for Magellan’s clinical strategy and policy. Amstutz, who will report to Barry M. Smith, chairman and chief executive officer, will begin on September 15, and will be based in Scottsdale, Ariz.
“Karen has significant experience developing and leading clinical strategy, as well as managing care management programs which have delivered clinical effectiveness and quality,” said Smith. “Her background as a practicing physician with active involvement in data analytics and the management of chronic diseases, as well as her experience successfully leading clinical strategy and operations for Medicare Advantage and Medicaid members at a national healthcare company will serve her well in this role. I look forward to working with Karen as Magellan continues to offer industry-leading programs and solutions across all of our lines of business.”
“Joining Magellan Health at this point in the company’s history is an exciting opportunity, as it further invests in innovative delivery models, cutting-edge technology and enhanced data analytics to drive improved outcomes and high-quality care for its members,” said Amstutz. “Magellan’s behavioral health, pharmacy and specialty solutions offerings provide compelling solutions to the marketplace to address many of the industry’s fast-growing, complex and high-cost areas of healthcare.”
Amstutz comes to Magellan from Evolent Health, where she was vice president of medical affairs, responsible for clinical effectiveness and operations for population health implemented in large health systems across the country. Amstutz developed quality improvement and clinical intervention strategies for partner health systems, and provided strategic direction to enterprise clinical program development, reporting and analytics functions, among other areas. Prior to her time at Evolent Health, Amstutz served as the vice president of medical affairs and senior medical director at xG Health Solutions, a healthcare start-up which assists health systems committed to value-based care succeed under value- and performance-based payment models. Amstutz also served as the vice president, medical director, care management and quality at WellPoint, where she was accountable for clinical strategy and operations, quality and medical cost management for managed Medicaid and Medicare Advantage, as well as for 33 million commercial members of large and small group plans nationally.
About Magellan Health: Headquartered in Avon, Conn., Magellan Health, Inc. is a healthcare management company that focuses on fast-growing, complex and high-cost areas of healthcare, with an emphasis on special population management. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. Magellan’s customers include health plans, managed care organizations, insurance companies, employers, labor unions, various military and government agencies, third party administrators, consultants and brokers. For more information, visit MagellanHealth.com.